Vets Now has this month launched a new fast track programme called 'Cutting Edge', which the company says is aimed at young, dynamic vets.
The 'Cutting Edge' initiative is apparently the first training programme of its kind in the UK and will see 40 graduates who graduated between 2006 and 2009 recruited into a 10 week fast track training programme, before they take up permanent positions in Vets Now clinics. Each recruit will get a salary package which will put them on £40k within 24 months.
Interviews and selection will be held mid-late August at a number of selection centres across the UK, with the first intake of 20 recruits commencing their fast track training programme on 4 October and taking up their positions in a Vets Now clinic in December.
A second intake of recruits to the programme will be selected during November, with these recruits taking up their positions on the fast track training late in January.
The programme is being spearheaded by Vets Now Clinical Director and experienced clinician and teacher in Emergency and Critical Care, Amanda Boag, MA VETMB DipACVIM DACVECC FHEA MRCVS who said: "This is a unique and hugely exciting opportunity for recently qualified vets to enter the field of Emergency and Critical Care. We're looking for dynamic and energetic young vets with a real passion for continuing their clinical development who feel they have what it takes to succeed in this exciting, and growing sector of veterinary medicine."
She added: "The recruits who we select will embark upon an intensive period of training over the 10 week period which will give them the necessary skills and knowledge to launch their career in ECC. They will also receive ongoing support during their first two years as a veterinary surgeon in a Vets Now clinic with a very generous CPD allowance. The initial 10 week period will be a combination of lectures and interactive seminars, practical training in our clinical skills laboratory and mentored work in our clinics. Developing clinical expertise and problem solving skills will clearly be the most significant component of the training but there will also be support and training in other vital skills including communication."
Until now, Vets Now would only employ veterinary surgeons with at least two years post-qualified small animal experience or who have completed their PDP. This new programme has been launched to attract and support young talent in making the move to this growing sector of veterinary medicine.
Recent graduates who are interested in developing a career in ECC are invited to apply in the first instance by contacting the Vets Now recruitment team on 01383 841181 or by emailing cuttingedge@vets-now.com.
The new initiative also has a Facebook page - www.facebook.com/vetsnowcutting edge and you can follow news and updates on the 'Cutting Edge' Twitter page at www.twitter.com/vncuttingedge.
CEVA Animal Health has published a trial which, according to the company, shows that horses suffering lameness caused by bone spavin can show marked improvement following treatment with a Tiludronate infusion, in combination with controlled exercise.
Bone spavin is a chronic aseptic osteoarthritis of the distal tarsal joints which, says CEVA, is considered to be one of the most common forms of hindlimb lameness in the horse.
The double-blind, multicentric, placebo-controlled trials were carried out on a total of 108 pleasure horses, show jumpers and eventers of a variety of sizes and breeds, all of which had been clinically diagnosed with bone spavin. The horses were rigorously selected, having to show clinical signs of spontaneous lameness of at least six weeks but less than a year's duration and had to be in daily exercise. Horses suffering proximal suspensory desmitis were excluded.
Horses were defined as suffering from bone spavin if they displayed a chronic hindlimb lameness which improved with distal tarsal joint analgesia and showed radiographic evidence of bony changes associated with bone spavin in the distal tarsal joints. The horses were treated at day zero with a single Tiludronate infusion or a placebo and reassessed 60 days later after a period of controlled exercise.
Eighty seven horses completed the trials, comprising 42 Tiludronate treated horses and 45 placebo cases. By day 60 approximately 60% of the Tiludronate treated horses had improved in lameness by two grades or more, scored on a ten point system.
Horses with bone spavin experience abnormal bone remodeling changes, occasionally with excessive bone resorption in the tarsal bones. Tiludronate works by regulating this bone remodeling through a decrease in the resorptive process, slowing down the degradation of the bone structure when the condition is progressing and alleviating the pain associated with abnormal bone lysis.
CEVA has recently produced a leaflet specifically to help horse owners to understand the diagnosis and treatment of bone spavin. For copies of this leaflet and CEVA's comprehensive veterinary brochure on the product please contact CEVA Animal Health on 01494 781510 or visit the website at http://www.tildren.com/
Tiludronate infusion in the treatment of bone spavin: A double blind placebo-controlled trial
Reference M. R. GOUGH*, D. THIBAUD† and R. K. W. SMITH‡ (*CEVA Animal Health, Bucks, UK; †CEVA Animal Health USA, Kansas, USA; and ‡Department of Veterinary Clinical Sciences, The Royal Veterinary College, University of London, UK). Equine vet. J. (2010) 42 (5) 381-387 doi: 10.1111/j.2042-3306.2010.00120.x
So, after months of speculation, the Panorama documentary: It shouldn't happen at a vets' finally aired last night. Early reaction from most of the profession seems to be one of mild relief that by focussing so heavily on Medivet, the documentary has left everyone else more or less unscathed.
There's also a great deal of sympathy for those hard-working and professional vets and nurses who work at Medivet. They're the biggest losers in all of this, tarred by the indefensible behaviour of a very small number of colleagues, and by the very nature of most of the filming in the documentary (give me a fish-eye lapel camera, and I could make even Mother Theresa look like a crack dealer).
But can everyone else really sit back, think 'not my problem', 'sensationalist rubbish', or 'it'll blow over in a week' and move on?
If you consider only the more headline-grabbing elements of the documentary, any of those would be a reasonable position to take. But look beyond 'Vet Makes Fraudulent Insurance Claim', and it seems the producers might accidentally have hit upon some big challenges facing the profession. Might now be a good moment to reflect on and debate some of these issues?
The first story covered by the documentary was that of an owner who'd found their cat 'weeing blood', taken it to Medivet and been quoted £815.05 for a bank of tests. They'd left in disgust, and visited another practice. This one gave a diagnosis without tests, the bill for which came to 75 quid, including £28 worth of food.
Veterinary costs were a recurring theme throughout the documentary. At the start, Jeremy Vine pointed out the £20,000 lifetime cost of owning a dog, and the £15,000 cost of owning a cat. He said vet bills have trebled in a decade. Mid-way through the programme, the voice-over read: "Veterinary medicine is increasingly high tech, and increasingly expensive. The new generation of vets is taught that working up to an accurate diagnosis may involve extensive tests. More veterinary work means more costs. And later in the documentary, Alex Lee, the reporter, was said to have found evidence of two clients that had spent over £100,000 on their pets over a ten year period.
At the end of it all, the real issue is not about the disparity between one vet's bill and another's, but whether the profession is becoming over-qualified or over-equipped for the job, and consequently at risk of pricing itself out of the market.
Commenting on state-of-the-art care, Professor Innes from the University of Liverpool said in the programme: "We would never push clients into procedures that are unnecessary, but if people want to access the best healthcare for their pet, that's up to them."
Surely every pet owner wants to access the best healthcare for their pet? Of course, Professor Innes is right, there is a market for complex procedures and diagnostic tests. But there's a very fine line between 'pushing' a client into a procedure, and recommending a procedure (to someone who feels emotionally duty-bound to do the best for their cherished pet).
For me, it was ironically one of the Medivet staff who seemed to hit the nail on the head when she said: "The 'Medivet Way' is to work it up to find out why straight away, so... And people can't afford it now really, you know."
Is the word 'Medivet' in her quote interchangeable with a growing list of practices? Does something need to give? Is it time to call a halt to the development of increasingly complex procedures and diagnostic tests developed to save the life of what is, after all, just a cat or a dog?
Or is it a question of veterinary surgeons ceasing to recommend any particular treatment above a certain cost, and instead simply laying out the options available to the client: "Mrs Jones, you've got three options here. Option one is my best guess, and I might be wrong. Option two is my best guess plus these tests, which will help confirm whether I am right and will cost x. Option three is referral to the world's leading expert, who is based in Dallas, but that'll give time for the MRI on board the specially chartered 747". I'm being flippant, but my point is a serious one: as more expensive treatment and diagnostic options become available, so it becomes ever riskier recommending them, rather than simply informing the owner of their choices.
The next story was an important one too. It was the one where a student nurse and the unqualified reporter were tasked with catheterising a dog unsupervised. They struggled. As did the dog. Thanks to the hidden camera, and the reporter interjecting: 'What a nightmare', it made for dramatic TV. But as many have commented in the VetSurgeon forums, a difficult to catheterise dog is not exactly out of the ordinary. And who thinks this was the first time the procedure has been done by lay staff?
More interesting was the polar opposite interpretations of the law on this issue expressed by Medivet on the one hand, and Professor Sandy Trees for the RCVS on the other. In response to the question of whether a trainee should be placing a catheter, Jeremy Vine read from a statement in which Medivet insisted that everything it allows its trainees to do is legal, and that there was no definitive list of procedures that could be carried out by trainees. Two minutes later, and we had Professor Trees appearing to contradict Medivet's statement.
Then we see the reporter and a student nurse taking a blood sample from a cat, before the arrival of a vet. Medivet says: "This procedure was completely legal, normal and was carried out at the direction of a vet. This means that the vet does not have to be present at the time. [The tasks] were not illegal. The trainee veterinary nurses were properly trained and experienced. RCVS inspectors have never raised this as an issue, and it is common practice." But when Jeremy Vine then asked Professor Trees: "Would it be OK for a student veterinary nurse to take a blood sample before a vet arrived into the practice", the answer is no. When pressed: "So supervision means that the vet has to be in the building", Professor Trees hesitates before delivering his more ambiguous reply: 'I would say so, yes'.
How on earth did that happen? How did one of the biggest veterinary groups come to be at loggerheads with the regulator on TV? Remember that Medivet would have had some time to prepare its response, and presumably had it checked by a team of lawyers first. Professor Trees may or may not have had the luxury of as much warning. Still, if el Presidente himself cannot give more than a personal opinion in answer to such an important question, something is amiss. After all, people's careers are at stake here.
The issue here is whether regulation needs to become more prescriptive. For example, is it fair that the responsibility for defining precisely what is 'minor surgery (not involving entry into a body cavity)', and therefore able to be performed by a qualified veterinary nurse, currently rests with the individual veterinary surgeon. And if it comes to it, the only way the veterinary surgeon is going to know whether he or she made the right call is if and when it comes to be tested in court.
Talk about closing the stable door after the horse has bolted.
Surely it is time now, particularly in the (like it or not) increasingly corporate and less personally accountable world we live in, for the profession and everyone in it to have clearer leadership in terms of what is and what is not acceptable.
I won't dwell on any of the other stories covered by the documentary, because I don't think any of them are individually revealing of very much.
A student nurse struck a dog. 'Walloped' according to the reporter; 'smacked' according to an onlooker. There's a difference. Either way, a difficult one to defend.
Then a member of staff (and I couldn't work out whether it was the vet or the nursing assistant) started playing with an anaesthetised kitten as if it were a puppet. That was damning for the lack of humanity it showed.
Next we saw a new grad trying to intubate a cat. For some reason, it didn't go as smoothly as it should. Some speculation in the VetSurgeon forums as to whether she applied the local anaesthetic correctly or not, but the cat was fine. Mistakes happen.
Next we saw a dog that had a condition which made it susceptible to cuts. A 'new girl' says she thinks she must have accidentally cut its pad as she closed the kennel door. Not the end of the world, except we then see the staff plotting to tell the owner that it happened before the dog arrived at the practice, and that they would need £13 worth of Fuciderm. Again, it isn't what you would call the crime of the century. But it was nevertheless a damning piece of film for the lack of honesty shown by the staff.
Then we had the case of the dodgy insurance claims, where the practice allegedly split what should have been one claim into three 'by accident', so that they could effectively increase the total amount the owner would be able to claim. Difficult to get really het up about this one. I mean, I know it's wrong. But it wasn't exactly in the same league as Lord Brocket taking the oxyacetylene torch to his car collection. And as far as I could see, the unwitting beneficiaries of this one were the dog and its owner. No, the real problem was that in the same breath as Medivet proclaimed its innocence, its employee was there in technicolor explaining exactly how and why the deed was done.
Guy Carter, one of the Medivet partners was next on the rack. The Panorama reporter alleged that he instructed staff to bill a client for a monitor that wasn't used. The company says it was. So it's their word against hers. Unfortunately, the company's word wasn't looking that good by this stage in the proceedings.
As I said earlier, these things don't individually tell anyone much. But collectively, I wonder whether they don't highlight another important issue, which is the apparent 'disconnect' (hate using the word like that, just can't think of a better alternative at this time of night) between what the public wants (i.e. a close, trusting relationship with an accountable James Herriot-type-figure, personified in the film by Bob Stevenson), and what the corporates can realistically deliver.
I was chatting about this with a locum vet this afternoon. His experience is that in small practices where the owner is present, there is always a better atmosphere. Staff take more pride in their work, and deliver a higher standard of care than in the corporates.
Isn't that really what the documentary showed? Yes, they were especially excruciating examples of how people behave when they don't have a real sense of ownership in a business. But isn't a lower, less personal standard of care an inevitable consequence of corporatisation?
Incidentally, my apologies for labelling Medivet a corporate rather than a partnership, but like it or not, that's the public perception of a chain.
Finally, the star of the show made his grand entrance. Kfir Segev, charged with recommending £2200 worth of MRI scan for a dog that was obviously dying. Now that is despicable. He's found guilty of unprofessional conduct, and struck off. I suppose 'vet commits fraud, is found out and punished' is not the stuff of which great documentaries are made, so Panorama tried to make something of the fact that he continued to work for 28 days whilst deciding whether to exercise his right to appeal. And? Perhaps sensing they still had a bit of a non-story on their hands, they tried to make an issue out of the fact that he'd continued to work as a practice manager after being struck off. It was all a bit lame, really.
Still, not as lame as the finale, which was the 'revelation' that Medivet collected blood from rescue dogs, in return for donations of food and supplies. Panorama claimed the blood was sold at a profit. Medivet claimed it is subsidised. Does anyone actually care either way?
Since the documentary was broadcast last night, Medivet has issued a further statement in which it does the honourable thing, and takes responsibility for everything it needed to. Medivet will recover from this. If the professionalism of the response is anything to go by, it will emerge stronger. Still, the big questions remain. How to address the spiralling costs that accompany the latest advances. Can the profession afford, any longer, to leave so much to the discretion of the individual, or is it time to demand a more prescriptive regulatory environment? And finally, how can the corporates deliver the kind of service that the public seems to want? Doubtless there will be some who'd like them to fail in this regard. But as we've just seen, it does nobody any favours if they are allowed to do so in a way that threatens to bring the whole profession into disrepute.
Pfizer Animal Health has launched a dedicated Equine Business Unit to provide a higher level of service and a comprehensive range of products to equine vets across the UK.
Created following the merger with Fort Dodge, the Pfizer Equine Business Unit is headed by Ben Lacey MA Vet MB MRCVS, who has previously held both technical and sales roles at Pfizer. Ben and his team have a brief to offer a breadth of product, support and flexibility not previously available to equine vets.
The product range offered by the Pfizer Equine Business Unit includes the Equest range of parasiticides; the Duvaxyn vaccines for Equine Herpes Virus, West Nile Virus and Rotavirus and products such as Equimidine and Torbugesic. Also offered are existing Pfizer brands such as the Equip vaccine range, the antibiotic Excenel Sterile Powder, the NSAID Rimadyl for Horses and Depo-MedroneV.
Five experienced account managers with a strong track record in the equine sector have been appointed by Pfizer to build relationships with equine vet practices on a regional basis. They are:
South East England Mark BakerWest Midlands, Cheshire, Wales Laurie MayEast Anglia, East Midlands Penny McCannSouth West, South Wales Anna CunninghamThe North, Scotland Alexandra Cox
Ben Lacey said: "Building our new team and combining the highly regarded products offered previously by both Fort Dodge and Pfizer has proved a stimulating process. We've also worked closely with many of our existing practice customers to look at how we can develop the service we provide to them.
"We're now able to offer a product range which I believe is unrivalled in the market and a highly committed team of equine professionals, who share a vision and passion for equine health. We're looking forward to building our business with both existing and new customers in the months ahead."
The Daily Mail has today published an interview with the 'nurse' who worked undercover at Medivet for tonight's Panorama documentary: It shouldn't happen at a vets (tonight, BBC1 9pm).
Looks like the communications departments at the RCVS, BVA and BSAVA will be run off their feet today. So far, the following radio stations and newspapers have run stories:
BBC Online has published a longer trailer for the programme here.BBC Radio 4 Today - interview with the mole, followed by Sandy Trees (in the recording of the entire programme, it starts at 1:09:05 on the iPlayer timeline)BBC Radio 5 live - interview with Jacquie Molyneux (not available on iPlayer)BBC Radio Tees - 7:50am interview with Bill Reilly (BVA)BBC Radio Somerset - 8:00am interview with Bill Reilly (BVA)BBC Radio Shropshire - 8:40am interview with Bill Reilly (BVA)Aberdeen Press & JournalBBC TwitterChina News (in Chinese)BBC Radio 2 - Jeremy Vine interviews Steve Leonard (starts at 1:10:56 on the iPlayer timeline. Continues through at least a couple of songs. At one point, Jeremy Vine says there are lots of reports coming into the show of good vets too!).dogmagazine.netThe Guardian (TV Review)
I'll be updating the list of news reports over the course of the day.
And reaction to the story elsewhere on the Internet ...
UK Labradoodle forumDigital SpyYahoo AnswersPet forumshttp://www.youtube.com/watch?v=31MgikMLneU (well worth watching, this one).Horse & Hound forums
Incidentally, in case anyone is asked for an interview, BVA has produced an advice sheet on the subject for its members, plus a briefing document. The association has also published a response to the Daily Mail story on its website.
CEVA Animal Health has published an information booklet on Q Fever to help broaden awareness and understanding of the disease.
Q Fever is an emerging, worldwide disease that affects goats, cattle and sheep as well as humans. It is caused by the bacterium Coxiella burnetii and can induce late abortions, metritis, fertility problems, mastitis and low vitality in neonates born from carrier animals.
The new booklet explains how the disease is transmitted, the symptoms, diagnosis and how it can be managed and prevented. CEVA already have expertise in the treatment of diseases caused by Coxiella burnetii and have developed a vaccine that has been used under temporary license to control outbreaks in France and the Netherlands.
To obtain a copy of the booklet please contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG. The proceedings from CEVA's recent symposium on Q fever, held in Marseilles in December 2009 are also available on request.
Genitrix has announced the launch of Prilben (benazapril hydrochloride). The product joins its 'Standards' range, created to offer veterinary practices cost-effective versions of frequently used products.
Prilben is indicated for the treatment of congestive heart failure in dogs and for chronic renal insufficiency in cats. It is provided in packs of 14 x 5mg tablets at a veterinary list price of £4.50, which equates to 32p per tablet.
Rob Watkins, Marketing Director at Genitrix, said: "Benazapril hydrochloride is a tried and trusted medicine used in countless practices and homes across the country every day. Prilben offers a win for both practices and pet owners because its pricing structure enables practices to maintain profitability on the product whilst still providing their clients with an economical alternative."
The first product in Genitrix' Standards range, Dormilan, was launched in late 2009 and offers fast-acting sedation and analgesia for dogs and cats.
The International Society of Feline Medicine (ISFM) has published 'Consensus Guidelines on the Long-term use of NSAIDs in cats' in the July 2010 edition of the Journal of Feline Medicine and Surgery.
The society says it has developed the guidelines in order to try and address the major welfare issue of cats suffering unremitting and untreated chronic pain. Until recently, NSAIDs had only been licensed for short-term use in cats, but with changing licensing indications and recommendations, they are now also increasingly used for long-term treatment of cats, for example in the management of osteoarthritis.
However, in most cases where long-term use of pain relief in cats is required, there are concomitant problems with other diseases or other drugs that are being given. According to the ISFM, one of the most common concerns is whether NSAIDs can be used to treat arthritis in older cats with kidney disease. The society says that because of concerns like these, and the potential for adverse effects, cats often receive no treatment at all, and their quality of life can be severely compromised.
For this reason, the ISFM set up an international expert panel to develop practical and rational guidelines on the long-term use of NSAIDs in cats. The aim was to provide guidelines that would empower clinicians, enabling them to make sensible and rational choices, and ensure much-needed therapy is not needlessly withheld from patients.
The panel was made up of Andrew Sparkes, Duncan Lascelles, Richard Malik, Sheilah Robertson, Margie Scherk, Polly Taylor, Llibertat Real Sampietro and Reidun Heiene.
Along with the veterinary information in the guidelines, the panel also developed a brief client-facing leaflet that can be given to owners when NSAIDs are prescribed for their cats - this leaflet provides simple, clear advice on why NSAIDs are used, why they are important, but also what simple precautions avoid adverse effects, with further advice on when to seek veterinary advice to reinforce the safety message.
Both of these publications are available to download from the website www.isfm.net/toolbox
The British Small Animal Veterinary Association has announced the appointment of Dr Frances Barr as Academic Director, tasked with developing the new BSAVA postgraduate qualification in association with the Open University, ready for launch in 2012.
Frances is a European Specialist in Veterinary Diagnostic Imaging, and a double diplomat of the Royal College of Veterinary Surgeons and the European College of Veterinary Diagnostic Imaging. She has worked both in practice and as an academic, with 26 years working in Higher Education, and has a long history of working as a BSAVA volunteer, eventually taking on the presidential mantle in 2007.
BSAVA says it aims to provide the best possible educational offering to the profession, particularly to those in practice. Grant Petrie, BSAVA President, said: "Producing a postgraduate qualification is a natural progression to BSAVA's current CPD offering - there is clearly a need for it and we have a strong legacy as a provider of quality CPD. We want to make sure that the profession is served well - with a programme designed by vets for vets. As a charity with education at the core of our remit, BSAVA is best positioned to create something that will keep investing in the knowledge and talent of the profession. However, we always knew that we would need an exceptional individual to oversee the programme, and, in Frances Barr, we know we have that person."
Frances said: "This will fill a really important need. Many practitioners have a real appetite for learning more about their particular area of interest. Of course, they can currently do this with general CPD courses, but this new qualification will provide a structured and focussed learning programme which is flexible enough to fit around the busiest lifestyle, yet challenging enough to make the qualification a personal achievement, one that will be well respected by the whole profession."
She added: "The proposed new certificates in small animal medicine and surgery will comprise a combination of traditional taught courses, a wide-range of web-based material that will include interactive sessions, and workplace-based projects. This is the way forward for practitioners and will lead the profession into a more secure future."
The qualifications will be aimed primarily at the general practitioner, so they are not designed to replace the European Diploma system or aspiring to provide specialised knowledge. Instead they will be created very much for the interested, busy practitioner for whom an accredited residency programme is not an option. Grant Petrie said: "Encouraging small animal practitioners to embark on a clinically useful, challenging yet achievable, highly regarded postgraduate qualification sits very well with the BSAVA's remit to promote excellence in small animal practice through education and science."
The BSAVA postgraduate programme will launch in 2012, with more information about registration available at Congress 2011 and online from April next year. Frances Barr will begin working with the Open University and the BSAVA team in November.
Agrimin has announced the launch of a new range of boluses for sheep and cattle that use 'eroding technology' to deliver a sustained supply of three trace elements for up to 180 days:
According to Agrimin, each bolus is designed to provide the full daily requirement of cobalt and selenium and the largest available daily supply of iodine to both cattle and sheep. The boluses do not contain any copper, an element known to cause issues in certain parts of the country, in closely managed dairy cows or in continental sheep breeds.
Each bolus is made up of two parts, held together by a soluble wrapper. After administration, the wrapper dissolves and the two halves remain in the reticulum where they erode and dissolve. This process delivers a continuous and regular supply of nutrients to the animal.
Agrimin's Dr Jamie Bennison said that the new range has been extensively trialled in New Zealand and at Glasgow Veterinary School: "Trials have confirmed a sustained release profile which ensures that iodine, selenium and cobalt levels are maintained throughout the active life of the bolus. In farm trials this has translated into higher levels of the elements in blood samples and improved animal productivity."
Treatment is one bolus per animal (48g for sheep; 160g for cattle) administered with an Agrimin bolus gun. One bolus is sufficient to meet the animal's full daily requirement for 180 days.
For more information about the 24•7 Iodine•Selenium•Cobalt range of cattle and sheep boluses, please visit http://www.agrimin.com/ or call 01652 688046.
Medivet, the practice group which is to feature in the forthcoming Panorama documentary It shouldn't happen at a vets' (9pm, July 22nd), has issued a statement concerning the programme.
The statement, which can be read in full here, includes an interview with a Medivet client who was in turn interviewed for the documentary:
New research released today by Petplan has revealed that at a time when marriage is in decline and the average child bearing age is increasing, a new breed of pet owner has emerged: women between the ages of 25 and 34 who bought their pet as a substitute for a child.
More than 10,000 pet owners were surveyed for the research and the results apparently reveal 'pet parenting' as a growing trend. According to the survey, women not only look to their furry friend for companionship but also treat them like they would a child, with nearly 70% buying them birthday and Christmas presents, 28% adapting their homes for their pet and 20% changing their holiday destinations to allow their pet to come along too.
Just like working parents, owners worry about leaving their pet alone when they're working. So much so that they make a concerted effort to make sure their pet is not left alone for more than five hours a day - employing dog walkers and cat sitters to stem their concern (approaching 1 in 7). When an 8 hour working day is the national norm and the average parent only spends 49 minutes a day with their children, this demonstrates considerable pet commitment.
Dr Deborah Wells, expert in the study of the psychology of the pet-human relationship said: "Dogs and cats can offer their owners many of the benefits frequently provided by children, including companionship, entertainment and happiness. For some owners, notably women, pets can provide a useful training ground in 'motherhood', in some cases helping to shape important decisions on whether or not children are to be a part of their future. For others, pets can serve as a child 'substitute', offering people who choose not to have, or cannot conceive, children, an outlet for emotional attachment and nurturing behaviour."
Petplan's marketing manager Alison Andrew said: "This pet parenting theme is one of the most significant trends to come out of Petplan's biggest body of research to date - the Petplan Pet Census - which looks into the realities of pet ownership. We see the amazing lengths that owners go to for their pets every day and the level of worry that goes with it. Our job is to give owners peace of mind through our insurance plans, so they can be confident their beloved companion will always receive the best care and treatment without having to worry about the financial costs. We want to use this research to truly understand modern pet ownership in the UK so that we can better provide help and guidance for our nation of pet lovers!"
If you'd like to take part in the Petplan Pet Census, documenting the picture of pet ownership in Britain, visit www.petplan.co.uk
Rob Rayward, an RCVS Orthopaedic Specialist at Davies Veterinary Specialists, Hertfordshire, is preparing to grease up and swim the murky waters of the English Channel this month, to raise funds for the Christian charity Derek Prince Ministries UK.
Rob is undertaking the 35km swim as a part of a Channel Swim Relay Team and has been in training for his chilly trip across one of the world's busiest shipping lanes for the past year. He is hoping to raise £1500 for the charity, which provides Christian teaching materials in over 1000 languages to Church leaders and Christian communities around the world. They also provide food and education to poor widows and orphans in Ethiopia.
Rob said: "Despite being a small animal vet I'm definitely not planning on doing the doggy paddle. All members of the team have different strengths and weaknesses but for me the cold water is proving to be a real challenge. It is likely to be about 16C on the day but as well as the cold we may have to swim part of it in the dark. Many people are aware that the Channel has debris floating in it but few are aware that we may also face jelly fish, basking sharks and if really lucky, sewage! We anticipate it taking us approximately 14 hours to complete the crossing but weather and tidal conditions can have a major impact on our time."
Rob will be completing his challenge when the conditions are favourable at some point between 19th and 28th July.
To sponsor him visit his JustGiving page at www.justgiving.com/rob-rayward.
All donations are gratefully received.
Dechra Veterinary Products has launched free online Fluid Therapy Calculators to help veterinary staff calculate their patients' fluid requirements.
There are two versions available, small animal and equine. Both are available as an online tool or as a download to your desktop (note that to get hold of the desktop version, you need to try out the online calculator first).
For small animals, there are three options available. The M1/M2/M3 Plan calculates simple multiplications of the maintenance rate, while the Comprehensive Plan calculates fluid required to provide maintenance requirements, correct dehydration or replace ongoing losses. The third option, the Simple Rate Calculator, is a tool for calculating resuscitation fluid rates and can also be used for large animals. The Equine Plan calculates fluid requirements and infusion rates for both adult horses and foals.
Dechra says it has launched the calculators as the next component of its Vetivex Fluid support package. Along with the Fluids Knowledge Programme, this initiative aims to help veterinary staff across the UK to deliver effective fluid therapy.
Larry King, Product Manager at Dechra, said: "The calculators are a quick and easy reference tool for today's busy vet. You simply fill in the body weight and animal type, key in a few details and you have an instant but very accurate fluid rate calculated for you. It saves time and effort and ensures the animal is given the correct amount of fluid. The more effective the fluid therapy regime the faster the animal recovers."
The free Fluid Therapy Calculator is just one of a number of tools Dechra uses to support its Vetivex range of fluids. There is a range of downloadable reference documents, charts and guides available on the website http://www.fluidtherapy.co.uk/ including the Fluid Knowledge Programme and a full CPD Programme focused on effective fluid therapy.
The long-awaited Panorama programme about the veterinary profession will air on Thursday 22 July at 9pm on BBC One.
Rumour has it that the programme will cover a range of issues, including the role of unqualified nursing staff in the practice, support for new graduates, over-charging in relation to insurance and regulation of corporate practices.
The RCVS says it expects increased public interest in the regulation of the profession following the programme and is gearing itself up to address any concerns it raises. A statement will be posted on www.rcvs.org.uk immediately following the programme, and the RCVS has said that it will work with the British Veterinary Association and other organisations to ensure that the robust nature of the regulatory system is communicated to the public, from undergraduate degrees through the Professional Development Phase and the Guide to Professional Conduct, to mandatory continuing professional development and the voluntary Practice Standards Scheme and Register for Veterinary Nurses.
In a statement issued today, the RCVS said: "We currently receive around 700 complaints a year - about one every 15 years of a member's practising life. It's a record to be proud of. However, if the programme raises areas of genuine concern, we will do all we can to act on them and we have already made it clear to the BBC that we would expect their support in this."
Dechra Pharmaceuticals has signed an agreement with Piedmont Pharmaceuticals LLC which gives Dechra exclusive worldwide rights to the sale and distribution of veterinary products which use Piedmont's proprietary soft chew platform to deliver the active ingredient.
The agreement will allow Dechra to conduct studies necessary to achieve regulatory filings and government approvals within the US, Europe and other key countries.
According to Dechra, Piedmont's soft chew formulation is a unique delivery technology which overcomes the traditional problems in formulating a broad range of active drug compounds in a highly palatable chewy treat for both cats and dogs.
Ian Page, CEO of Dechra Pharmaceuticals PLC, said: "We are very excited about licensing this unique delivery technology, which will be the first soft chew product with this new patent pending technology in the veterinary market. The agreement will provide Dechra with the opportunity to expand our presence in the companion animal market with a truly differentiated product."Roland Johnson, Chairman and CEO of Piedmont Pharmaceuticals, said: "This is our initial development partnership for our soft chew technology and we welcome the opportunity to license our technology to Dechra. Our goal is to provide pet owners the added benefit of a tasty treat at medicine time, creating a fun and rewarding interaction, while improving compliance with the vet prescribed treatment regimen."
Members of Parliament have recognised the British Veterinary Association's contribution to the promotion of microchipping dogs and the campaign for compulsory microchipping through an Early Day Motion (EDM) tabled by Andrew Rosindell MP (Conservative, Romford).
The EDM is gaining signatures from across all political parties as MPs show their support for a compulsory microchipping scheme that would have a significant and positive welfare impact on dogs by:
The EDM is also supported by Dogs Trust (who coordinated the EDM), Cats Protection, Blue Cross, and NOAH (National Office for Animal Health).
Earlier this week Welsh Rural Affairs Minister Elin Jones AM announced proposals for the compulsory microchipping of all dogs and puppies sold or homed by licensed breeders, to improve traceability.
Professor Bill Reilly, President of the British Veterinary Association (BVA), said: "Microchipping is part of responsible pet ownership and the BVA believes that all dogs should be permanently identified by microchip before the first change of ownership or at the first veterinary examination.
"Compulsory microchipping allows stray dogs to be reunited with their owners and would help the authorities to crack down on shameful puppy farms, where the health and welfare of both puppies and bitches is compromised, by improving the traceability of the animals.
"It could also assist with the reporting of hereditary health problems and surgical procedures to help us gain as much knowledge and research as we can to improve the health of all dogs.
"I would urge all Members of Parliament to show their support for dogs and their owners by signing this EDM."
The EU Commission has approved the marketing authorisation variation of Boehringer Ingelheim's PCV2 vaccine Ingelvac CircoFLEX. This approval allows the combined use of the pig vaccines Ingelvac CircoFLEX and Ingelvac MycoFLEX in the European Union.
Boehringer says it will market this unique vaccine concept under the name FLEXcombo. The company highlights that protection against two of the most prominent and costly pig diseases, Porcine Circovirus Disease (PCVD) and Enzootic Pneumonia, can now be achieved with a single injection instead of up to four injections. More than 70% of European pigs are currently vaccinated against both these diseases.
According to the company, the combined use of Ingelvac CircoFLEX and Ingelvac MycoFLEX is already registered and widely used in North America and Asia. It is globally the first and only product combination of its kind.
Dr. Joachim Hasenmaier, global head of Animal Health within BI said: "We are very proud that we can now also supply EU veterinarians and farmers with this latest innovation that will help tremendously in reducing the number of injections to pigs, supporting the wellbeing of the animals and the farm economics by saving a substantial amount of labour."
Animalcare has launched a new broad spectrum fluoroquinolone antimicrobial (Enrofloxacin) which the company says is highly effective in the treatment of a wide range of conditions and easy to inject, with excellent tissue penetration.
Enrocare solution for injection is presented in three strengths: A 25mg/ml (2.5%) injection for dogs, cats and exotic animals including reptiles, small mammals and avian species. The 50mg/ml (5%) injection is licensed for use in cattle, pigs, dogs and cats, whilst the 100mg/ml (10%) injection is licensed for cattle and pigs. In the case of dogs and cats a single daily dose is needed.
Animalcare says it has priced Enrocare competitively. In addition, the range has been launched with three offers: "Buy one get one free on the 50 and 100mg/ml" and "Buy two get one free offer" on the 25mg/ml pack size. These offers will last for four months until the end of September.
In cattle, Enrocare 50mg/ml, given by the subcutaneous route, is licensed for respiratory disease of bacterial or mycoplasmal origin and the 100mg/ml strength is licenced for both respiratory disease and E.coli mastitis (the latter given by slow intravenous injection). According to Animalcare, its low dose volume makes it particularly suitable for the treatment of respiratory disease in calves. In pigs >25kg Enrocare is licensed for the treatment of the respiratory and alimentary tract diseases of bacterial or mycoplasmal origin and multi-factorial diseases such as atrophic rhinitis and enzootic pneumonia.
Tony Liepman, Animalcare Market Manager said: "The recent successful launch of Cephacare flavour raised Animalcare's profile as a supplier of more up-to-date antibiotics and this is our latest addition which offers excellent efficacy at an attractive price."
Dechra Veterinary Products has produced a pair of presentations, aimed at pet owners, for vets to use in receptions and at client events. The presentations cover canine hyperadrenocorticism, aka Cushing's syndrome, and feline hyperthyroidism.
Matthew Olsen, Product Manager, said: "We are committed to delivering a wide range of support materials and tools to enable vets to provide help and information to their customers. We have developed an owners' booklet on both Cushing's and hyperthyroidism and have now backed this up with PowerPoint presentations for vets to use with their clients. Some veterinary practices are using technology to revolutionise waiting room displays and we have responded to their needs by producing a presentation they can use on their waiting room information screens."
The Dechra Hyperadrenocorticism presentation covers what Cushing's is, what causes it and what owners need to look for. The presentation also explains the treatment options available. The Hyperthyroidism presentation details what the condition is and gives information on the thyroid gland. It highlights what cat owners need to look out for, including weight loss in spite of a ravenous appetite, increased fluid intake and increased restlessness. The presentation also advises people of what to do should they suspect their cat has hyperthyroidism and what the treatment options are.
Garden Lodge Veterinary Clinic in Holywood, County Down, has used the Hyperthyroidism presentation at both its practices. Partner Tom Fitzsimons said: "We have used the presentation on our reception information screens. The presentation has raised owners' awareness and shown them it is a manageable condition. It's led to an increase in the number of cats we are now testing for Hyperthyrodism. We also plan to run the Cushing's presentation in the future."
Veterinary Practices interested in getting hold of a free copy of the Hyperthyrodism and Hyperadrenocorticism presentations should contact Matthew Olsen at Dechra on 01743 441 632 or email matthew.olsen@dechra.com
For veterinary surgeons and VNs who missed out on the BVDA 'Improving Periodontal Health' lecture tour last year, a further six have been organised for this autumn.
Speakers include Norman Johnston BVM&S, MRCVS, Ex President of the European Veterinary Dental College, John Robinson BDS (Lond) Dentist to the Veterinary Profession and Lisa Milella BVSc, MRCVS President of the British Veterinary Dental Association (BVDA). This year's events see the content extended to include resorptive lesions, fractured teeth and dental radiography with greater emphasis on feline oral care.
According to Lisa, the 2010 lecture series helped alert vets and VNs to the importance of oral health, benefitting both pet and practice. "It takes five years at vet school to qualify yet only three or four days are devoted to dentistry, so it's no surprise that many vets and VNs enter the profession with only a basic understanding of oral health.
"We know that four out of five dogs over the age of three show signs of periodontal disease but unfortunately many go untreated. This is mainly because the problems that this can lead to are not fully understood."
She added: "These seminars will not only help delegates to recognise early signs of oral disease but also offer practical guidance on how practices can educate pet owners in the importance of oral care."
Lisa believes that both practices and owners benefit from good oral hygiene programmes. "As a profession we need to do more to help educate pet owners in the value of good oral care. Practices should be talking to their clients from day one about preventative programmes, rather than wait until the damage is done."
The six UK events are:
The evening seminars, which are open to both vets and nurses, contribute two hours CPD and cost £35 per person and £25 for each subsequent delegate. A special group rate of £100.00 is available for any practice that wishes to send a group of four. For anyone wanting to reserve a place, please call the BVDA lecture tour reservation line centre on 01664 415 503.
John Swinney MSP, Cabinet Secretary for Finance and Sustainable Growth, oficially opened the award-winning £10.5 million Small Animal Hospital for the Faculty of Veterinary Medicine, University of Glasgow today.
Designed by Archial Architects, the Small Animal Hospital provides state of the art services for animal owners and referring practitioners throughout Scotland and Northern England, including advanced diagnostic, therapeutic and surgical techniques.
Archial's design for the Small Animal Hospital has already won a string of awards, including the prestigious RIAS Andrew Doolan Best Building in Scotland Award, a RIBA Regional Award and the Supreme Award from the Glasgow Institute of Architects.
Archial Architects has confirmed that it is to donate £2,500 from the Andrew Doolan Prize fund to the Small Animal Hospital.
The findings of a Canine Vector Borne Disease (CVBD) prevention field study, published in Veterinary Parasitology today, have demonstrated the efficacy of Advantix in repelling ticks and sandflies, thus reducing the risk of potentially deadly diseases.
The study, conducted over two years by a team headed by Professor Domenico Otranto of the Faculty of Veterinary Medicine (Universitá degli Studi di Bari) Italy, with diagnostic support from a team led by Dr. Edward Breitschwerdt at the North Carolina State University, USA, found that dogs treated regularly with Advantix spot-on had a greater than 90% reduction in CVBD cases, including a 100% reduction in new cases of potentially deadly leishmaniosis and a 94.6% decrease in ehrlichiosis.
The study also found that Advantix provided 97.9% protection against tick infestation, compared to untreated dogs, where 100% were infested at the peak of the season. The level of protection offered by Advantix was apparently all the more notable because of particularly large numbers of ticks and sand flies and high prevalence of associated diseases like leishmaniosis or babesiosis in the area of the study.
Prof. Otranto said: "Our study shows the importance of protecting dogs with an effective treatment that repels as well as kills parasites like ticks and sand flies. Despite the high challenge faced by the dogs in our study, nearly all our treated dogs remained free from ticks throughout most of the study, and more than 90% remained free from CVBDs for the whole study time.
"Because we included naïve sentinel beagles in the study, we were also able to model what would happen to dogs travelling to areas where CVBDs are present. We found that by the end of the study, only the Advantix-treated beagles remained protected from infection, while 80% of the untreated beagles were infected with a CVBD. This demonstrates the very real need to protect dogs that are travelling to endemic areas."
According to Bayer, the study showed some interesting results with dogs that were positive with CVBDs when they entered the study. Of these, half of those treated with Advantix were negative for CVBDs at the end of treatment, compared with only 13% of untreated dogs. This suggests the potential for natural clearance of CVBDs if a repellent treatment is used to prevent new transmissions.
Bayer says the study was extremely comprehensive, studying both indigenous and introduced naïve puppies, monitoring for several CVBDs and working with Dr. Breitschwerdt's team in the USA to use highly sensitive molecular testing techniques to ensure optimal diagnostic accuracy. Dr. Breitschwerdt said: "This is the most comprehensive study, to my knowledge, ever conducted testing the efficacy of a repellent ectoparasiticide to prevent the transmission of a spectrum of CVBDs in young dogs."
Leading parasitologist Dr. Luis Cardoso of the University of Trás-os-Montes e Alto Douro, Portugal said: "Thanks to this study we can see just how effective a treatment that repels as well as kills can be."
Amongst the research being presented is 'Stress Reduction in Children', a Mars-funded study in which 75 male children were monitored to see how their levels of the stress-hormone cortisol varied when they were exposed to mild social stresses. The study found that children with a dog present showed significantly lower levels of the stress-hormone than those with a friendly adult present. In addition, the more the children stroked and interacted with the dog, the further their levels of cortisol decreased.
Sandra McCune, Research Manager for the Human-Companion Animal Bond Research Programme at Mars Petcare's Waltham Centre for Pet Nutrition (there's a job title-and-a-half) said: "Pet owners will tell you just how much their pet means to them but it is research such as this that proves just how fundamental and important the bond is between people and pets. These studies provide us with valuable insight into this special bond and the health benefits of owning a pet."
Genitrix has taken on the exclusive UK distribution of the Oxbow Professional range of premium recovery diets for herbivores and carnivores.
The Oxbow range was developed in the USA, covers a wide range of exotic species, and is offered in multiple pack sizes to ensure ease of use and cost effectiveness. Key products within the range include Critical Care, Critical Care Fine Grind and new Carnivore Care.
Carnivore Care is a recovery diet for carnivores including cats, ferrets, raptors and snakes, which are unwilling or unable to eat their normal diet. Developed specifically for carnivorous mammals, reptiles and birds, it contains easily digestible proteins, as well as high taurine and L-carnitine in a powdered formula which is easy to mix. It can be self fed, fed by syringe or even by tube to cats, ferrets, raptors, and other carnivorous small mammals and reptiles. It is used for conditions including malnutrition, severe weight loss, appetite stimulation, gastroenteritis, pre and post surgical care and as a medication carrier.
Critical Care is a recovery diet for herbivores, including rabbits, guinea pigs, hamsters, tortoises and other herbivorous mammals and reptiles. Formulated to contain all essential nutrients, as well as timothy hay to ensure proper gut physiology and digestion, it can be self fed or fed by syringe and is used in cases including gastrointestinal stasis, severe weight loss, dental disease/post extraction, for gastric hair balls and pre and post surgery
Critical Care Fine Grind is a recovery food which is particularly suitable in cases where tube feeding is required. Formulated to contain timothy hay and essential nutrients, it is offered in a fine particle size to ensure easy flow through nasogastric tubes and syringes. It can be used to feed herbivorous mammals and reptiles unwilling or unable to eat due to illness, surgery or poor nutritional status.
John Chitty BVetMed, CertZooMed, CBiol, MIBiol, MRCVS of the JC Exotic Pet Consultancy said: "In my opinion, the Oxbow Professional Line is the best recovery diet range on the market as it gives vets a variety of high quality options for multiple species. It can make really make the difference in a successful recovery."
Howard Wilder, Genitrix' Managing Director, said: "We're focused on delivering innovative products for companion animals and exotic pets which advance veterinary care and provide revenue opportunities for veterinary practices.
"The Oxbow range covers a uniquely wide range of species giving vets a flexible 'one range fits all' recovery care diet for convalescing pets, which has been well researched and formulated. We're delighted to launch the Oxbow Professional range in the UK and believe many veterinary practices will find it a beneficial addition to their armoury."